Bio Path | BPTH - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Baxter International USD 1.09B 87M 2026-03
Bio Path USD 5.16M 260K 2026-03
Cipla INR 32.3B 1.95B 2026-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Karyopharm Therapeutics USD 4M 1.39M 2025-12